A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

  1. Coveler, A.L.
  2. Reilley, M.J.
  3. Zalupski, M.
  4. Macarulla, T.
  5. Fountzilas, C.
  6. Ponz-Sarvisé, M.
  7. Nagrial, A.
  8. Uboha, N.V.
  9. Frentzas, S.
  10. Overman, M.
  11. Noonan, A.
  12. Messersmith, W.A.
  13. Pavlakis, N.
  14. Mettu, N.B.
  15. Bisha, I.
  16. Wang, Y.
  17. Smith, P.
  18. Murtomaki, E.
  19. Bielska, A.A.
  20. Bragulat, V.
  21. Cooper, Z.A.
  22. Kumar, R.
  23. Spigel, D.R.
Revista:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Any de publicació: 2024

Volum: 30

Número: 20

Pàgines: 4609-4617

Tipus: Article

DOI: 10.1158/1078-0432.CCR-24-0499 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus